查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療外骨骼市場——規模、份額、趨勢分析、機會和預測：按類型、流動性別、組件、應用和地區劃分（2019-2029 年）
市場調查報告書
商品編碼
1249969

全球醫療外骨骼市場——規模、份額、趨勢分析、機會和預測：按類型、流動性別、組件、應用和地區劃分（2019-2029 年）

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Mobility ; By Component ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2029 年，全球醫療外骨骼市場規模將從 2022 年的 3.2762 億美元達到 20.724 億美元，在 2023-2029 年的預測期內以 30.2% 的複合年增長率增長。預計健康增長。 市場的主要增長因素是世界人口老齡化加劇，醫療設備在汽車、軍事和國防、建築等各個行業的使用不斷增加，以及中風發病率上升。

本報告研究和分析全球醫療外骨骼市場，提供市場規模和預測、細分市場分析、區域分析、公司概況等。

內容

第一章研究框架

第 2 章執行摘要

第三章全球醫療外骨骼市場回顧

  • 應用價值鏈分析
  • DROC 分析
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 技術進步/最新發展
  • 監管框架
  • 波特的五力分析

第 4 章全球醫療外骨骼市場概述

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
      • 動力外骨骼
      • 被動外骨骼
    • 流動性別
      • 固定類型
      • 可移動
    • 按組件
      • 硬件
      • 軟件
    • 通過使用
      • 脊髓損傷
      • 中風
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲

第五章北美醫用外骨骼市場

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
    • 流動性別
    • 按組件
    • 通過使用
    • 按國家
      • 美國
      • 加拿大

第 6 章歐洲醫用外骨骼市場

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
    • 流動性別
    • 按組件
    • 通過使用
    • 按國家
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲

第七章亞太醫用外骨骼市場

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
    • 流動性別
    • 按組件
    • 通過使用
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太其他地區

第八章拉丁美洲醫用外骨骼市場

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
    • 流動性別
    • 按組件
    • 通過使用
    • 按國家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第9章中東和非洲醫用外骨骼市場

  • 市場規模和預測（2019-2029 年）
    • 數量
  • 市場份額和預測
    • 按類型
    • 流動性別
    • 按組件
    • 通過使用
    • 按國家
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 其他中東和非洲地區

第10章競爭格局

  • 主要公司及其類型列表
  • 全球醫用外骨骼企業市場份額分析（2022年）
  • 競爭基準：按管理參數
  • 重大戰略發展（合併、收購、合作等）

第 11 章 COVID-19 對全球醫用外骨骼市場的影響

第12章公司概況（公司概況、財務矩陣、競爭格局、主要人力資源、主要競爭對手、聯繫人、戰略前景、SWOT分析）

  • Ekso Bionics
  • ReWalk Robotics
  • PARKER HANNIFIN CORP
  • CYBERDYNE INC.
  • BIONIK
  • Rex Bionics Ltd.
  • B-Temia
  • Bioventus
  • Hocoma
  • Wearable Robotics srl
  • ExoAtlet
  • Meditouch
  • Suit X
  • MarsiBionics
  • Rehab-Robotics Company Limited
  • Myomo Inc.
  • 其他知名公司

第 13 章關鍵戰略建議

第 14 章研究方法論

簡介目錄
Product Code: BWC23215

Global Medical Exoskeleton Market Size Zooming More Than 6X to Reach USD 2.1 Billion by 2029.

Global medical exoskeleton market is flourishing because of rapid adoption of technology advancements to address the healthcare need of aging world population and people with physical disabilities.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global medical exoskeleton market size at USD 327.62 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global medical exoskeleton market size to grow at a robust CAGR of 30.2% reaching a value of USD 2,072.40 million by 2029. Major growth factors of global medical exoskeleton market include growing elderly population across the world, rising rates of medical device utilization in various industries, such as automobile, military, defense, and construction, and increasing stroke incidences. The growing number of patients with physical disabilities worldwide will drive the medical exoskeleton market. The number of people with physical disabilities is rapidly increasing as a result of car accidents, strokes, and serious injuries, which should encourage the market growth. Strokes are more common in the elderly population. According to the United States Census Bureau, the number of Americans aged 65 and up will more than double by 2050, which could boost the demand for medical exoskeleton across the countries. As a result, the demand for rehabilitation is expected to fuel the growth of the medical exoskeleton market. Also, the increasing prevalence of spinal cord injuries (SCI) is likely to increase demand across the global market during the forecast period. However, regulatory challenges for securing approvals for medical is anticipated to restrain the global medical exoskeleton market during the period in analysis.

Global Medical Exoskeleton Market - Overview:

Robotics is an application of engineering aimed at replacing humans with menial duties, whereas exoskeletons are applications of robotics and bio-mechatronics aimed at augmenting humans while performing a variety of tasks. A robotic suit, powered armor, wearable machine, power jacket, and exo-frame or suit are all synonyms for the exoskeleton. The field of exoskeleton systems is constantly evolving in the current context. Exoskeletons are employed in a variety of industries, including military, civilian, and rehabilitation, to boost soldiers' travel and loading capacities, to strengthen an operator's load-handling capabilities, and to improve lost functionality and patient life. It is also used to treat musculoskeletal diseases. It aids physical therapists in training individuals with motor nerve degeneration and motor cognitive limitations. Exoskeletons are also used in rehabilitation, particularly inpatient training and movement. Wearable exoskeletons are gaining popularity due to the high need for assistive technology in the medical profession, specifically to address concerns about an aging society. Other medical issues, such as aiding trauma victims, paraplegics, spinal cord injured individuals, and rehabilitation, are also important.

Impact of COVID-19 on Global Medical Exoskeleton Market

COVID-19 pandemic adversely affected the worldwide economy, disrupting supply and demand chains and increasing unemployment rates, resulting in overall economic uncertainty. According to Ekso Bionics' 2020 annual report, revenue income decreased by 36% in FY2020 compared to FY2019 due to a substantial reduction in medical device sales. Furthermore, according to the annual report, the demand for exoskeleton-related items dropped by 38% at the start of the pandemic, resulting in 61 bookings in 2020 as opposed to 98 bookings in 2019. Also, the pandemic led to a shortage of healthcare workers, which has made it difficult for hospitals and clinics to implement medical exoskeletons that require trained personnel to operate. However, the pandemic had a positive impact due to a surge in the number of patients with respiratory issues, and medical exoskeletons were used to support their respiratory function. Also, the rising emphasis on telemedicine influenced the medical exoskeleton market. As the pandemic limited in-person consultations, telemedicine has developed as an important method for healthcare practitioners to give care remotely. As a result, there was a demand for medical exoskeletons that may be used in telemedicine consultations. Hence, medical exoskeletons with remote monitoring and control capabilities have become increasingly popular.

Global Medical Exoskeleton Market - By Type:

By type, global medical exoskeleton market is bifurcated into Powered Exoskeleton and Passive Exoskeleton segments. The powered exoskeleton segment dominated the exoskeleton market in 2022 owing to the increasing use of powered exoskeleton solutions in numerous industries to improve personal safety and productivity. Furthermore, the advantages of powered technology items include smoother lifting motion, less strain on the worker's body, higher strength, force multiplier, and increased productivity.

Competitive Landscape

Major players operating in global medical exoskeleton market include Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN CORP, CYBERDYNE INC., BIONIK, Rex Bionics Ltd., B-Temia, Bioventus, Hocoma, Wearable Robotics srl, ExoAtlet, Meditouch, Suit X, MarsiBionics, Rehab-Robotics Company Limited, and Myomo Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Medical Exoskeleton Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Medical Exoskeleton Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Exoskeleton Market Insights

  • 3.1. Application Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Number of People with Physical Disabilities
      • 3.2.1.2. Advancement in Technology
    • 3.2.2. Restraints
      • 3.2.2.1. Regulatory Challenges for Securing Approvals for Medical Exoskeletons
    • 3.2.3. Opportunities
      • 3.2.3.1. Introduction of Soft Actuators
    • 3.2.4. Challenges
      • 3.2.4.1. High Equipment Cost
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Exoskeleton Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Powered Exoskeleton
      • 4.2.1.2. Passive Exoskeleton
    • 4.2.2. By Mobility
      • 4.2.2.1. Stationary
      • 4.2.2.2. Mobile
    • 4.2.3. By Component
      • 4.2.3.1. Hardware
      • 4.2.3.2. Software
    • 4.2.4. By Application
      • 4.2.4.1. Spinal Cord Injury
      • 4.2.4.2. Stroke
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Medical Exoskeleton Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Mobility
    • 5.2.3. By Component
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Type
      • 5.2.5.1.2. By Mobility
      • 5.2.5.1.3. By Component
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Type
      • 5.2.5.2.2. By Mobility
      • 5.2.5.2.3. By Component
      • 5.2.5.2.4. By Application

6. Europe Medical Exoskeleton Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mobility
    • 6.2.3. By Component
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Type
      • 6.2.5.1.2. By Mobility
      • 6.2.5.1.3. By Component
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Type
      • 6.2.5.2.2. By Mobility
      • 6.2.5.2.3. By Component
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Type
      • 6.2.5.3.2. By Mobility
      • 6.2.5.3.3. By Component
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Type
      • 6.2.5.4.2. By Mobility
      • 6.2.5.4.3. By Component
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Type
      • 6.2.5.5.2. By Mobility
      • 6.2.5.5.3. By Component
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Type
      • 6.2.5.6.2. By Mobility
      • 6.2.5.6.3. By Component
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Type
      • 6.2.5.7.2. By Mobility
      • 6.2.5.7.3. By Component
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Type
      • 6.2.5.8.2. By Mobility
      • 6.2.5.8.3. By Component
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Type
      • 6.2.5.9.2. By Mobility
      • 6.2.5.9.3. By Component
      • 6.2.5.9.4. By Application

7. Asia-Pacific Medical Exoskeleton Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mobility
    • 7.2.3. By Component
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Type
      • 7.2.5.1.2. By Mobility
      • 7.2.5.1.3. By Component
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Type
      • 7.2.5.2.2. By Mobility
      • 7.2.5.2.3. By Component
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Type
      • 7.2.5.3.2. By Mobility
      • 7.2.5.3.3. By Component
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Type
      • 7.2.5.4.2. By Mobility
      • 7.2.5.4.3. By Component
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Type
      • 7.2.5.5.2. By Mobility
      • 7.2.5.5.3. By Component
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Type
      • 7.2.5.6.2. By Mobility
      • 7.2.5.6.3. By Component
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Type
      • 7.2.5.7.2. By Mobility
      • 7.2.5.7.3. By Component
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Type
      • 7.2.5.8.2. By Mobility
      • 7.2.5.8.3. By Component
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Type
      • 7.2.5.9.2. By Mobility
      • 7.2.5.9.3. By Component
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Type
      • 7.2.5.10.2. By Mobility
      • 7.2.5.10.3. By Component
      • 7.2.5.10.4. By Application

8. Latin America Medical Exoskeleton Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mobility
    • 8.2.3. By Component
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Type
      • 8.2.5.1.2. By Mobility
      • 8.2.5.1.3. By Component
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Type
      • 8.2.5.2.2. By Mobility
      • 8.2.5.2.3. By Component
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Type
      • 8.2.5.3.2. By Mobility
      • 8.2.5.3.3. By Component
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Type
      • 8.2.5.4.2. By Mobility
      • 8.2.5.4.3. By Component
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Type
      • 8.2.5.5.2. By Mobility
      • 8.2.5.5.3. By Component
      • 8.2.5.5.4. By Application

9. Middle East & Africa Medical Exoskeleton Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mobility
    • 9.2.3. By Component
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Type
      • 9.2.5.1.2. By Mobility
      • 9.2.5.1.3. By Component
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Type
      • 9.2.5.2.2. By Mobility
      • 9.2.5.2.3. By Component
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Type
      • 9.2.5.3.2. By Mobility
      • 9.2.5.3.3. By Component
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Type
      • 9.2.5.4.2. By Mobility
      • 9.2.5.4.3. By Component
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Type
      • 9.2.5.5.2. By Mobility
      • 9.2.5.5.3. By Component
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Type
      • 9.2.5.6.2. By Mobility
      • 9.2.5.6.3. By Component
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Type
      • 9.2.5.7.2. By Mobility
      • 9.2.5.7.3. By Component
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Type
      • 9.2.5.8.2. By Mobility
      • 9.2.5.8.3. By Component
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Types
  • 10.2. Global Medical Exoskeleton Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Exoskeleton Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Ekso Bionics
  • 12.2. ReWalk Robotics
  • 12.3. PARKER HANNIFIN CORP
  • 12.4. CYBERDYNE INC.
  • 12.5. BIONIK
  • 12.6. Rex Bionics Ltd.,
  • 12.7. B-Temia
  • 12.8. Bioventus
  • 12.9. Hocoma
  • 12.10. Wearable Robotics srl
  • 12.11. ExoAtlet
  • 12.12. Meditouch
  • 12.13. Suit X
  • 12.14. MarsiBionics
  • 12.15. Rehab-Robotics Company Limited
  • 12.16. Myomo Inc.
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations